中东和非洲慢性疾病管理市场，按类型（解决方案和服务）、解决方案类型（本地解决方案、基于云的解决方案、基于 Web 的解决方案）、服务类型（教育服务、实施服务、咨询服务和其他）、疾病指征（心血管疾病 (CVD)、糖尿病、慢性阻塞性肺病 (COPD)、关节炎、哮喘、癌症和其他）、最终用户（医疗保健提供者、医疗保健付款人、其他）、国家（沙特阿拉伯、南非、阿联酋、以色列、埃及和中东和非洲其他地区）行业趋势和预测到 2028 年
市场分析和洞察：中东和非洲慢性病管理市场
慢性病管理市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 13.7%，预计到 2028 年将达到 5.9109 亿美元。慢性病患病率的不断上升预计将成为慢性病管理市场发展的驱动力。
慢性病管理 (CDM) 是一种持续的护理和支持，旨在为患有慢性疾病的个人提供他们所需的医疗保健、知识、技能和资源，以便他们更好地进行日常管理。它主要由各种软件和服务提供。慢性病管理通过综合护理预防或尽量减少疾病的影响，有助于降低医疗保健成本并改善慢性病患者的生活质量。
老年人口的增加预计将推动慢性病管理市场的发展。缺乏可及性预计将制约慢性病管理市场的发展。新技术进步的激增预计将为慢性病管理市场创造机会。缺乏可及性预计将对慢性病管理市场构成挑战。
慢性病管理市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和慢性病管理市场情况，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
慢性病管理市场范围和市场规模
The chronic disease management market is segmented on the basis of the type, solution type, service type, disease indication and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to surge in novel technological advancement.
- On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on-premise solution segment is expected to dominate the chronic disease management market due to rising strategic initiatives by key players.
- On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, implementation services segment is expected to dominate the chronic disease management market due to increasing prevalence of chronic diseases.
- On the basis of disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to increased reimbursement policies.
- On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers and others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to rise in awareness regarding the healthcare management service.
Middle East and Africa Chronic Disease Management Market Country Level Analysis
Middle East and Africa chronic disease management market is analyzed and market size information is provided by the country, type, solution type, service type, disease indication and end user as referenced above.
The countries covered in the Middle East and Africa chronic disease management market report are the Saudi Arabia, South Africa, UAE, Israel, Egypt and rest of Middle East and Africa.
Saudi Arabia is expected to dominate the Middle East and Africa chronic disease management market due to the presence of major market players and increased technological advancement in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to enhance the Awareness for Chronic Disease Management is Boosting the Chronic Disease Management Market
The chronic disease management market also provides you with detailed market analysis for every country growth in chronic disease management market. Additionally, it provides the detail information regarding the chronic disease management market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Chronic Disease Management Market Share Analysis
The chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East and Africa chronic disease management market.
The major companies dealing in the Middle East and Africa chronic disease management market report are Koninklijke Philips N.V., Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, Health Catalyst, ExlServings Holdings, Inc., ScienceSoft USA Corporation, Infosys Limited, IBM Corporation among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the chronic disease management market.
For instance,
- In April 2021, IBM Corporation launches advanced storage solutions designed to simplify data accessibility and availability across hybrid clouds. This new solution launch by parent organization IBM Corporation has enhanced the company’s overall revenue for market.
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业等策略正在增强公司在慢性病管理市场的影响力，这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS
5.1 REGULATION IN THE UNITED STATES:
5.2 GOVERNING REGULATIONS:
5.3 CPT CODES:
5.4 PRACTITIONER ELIGIBILITY:
5.5 PATIENT ELIGIBILITY:
5.6 REQUIREMENTS:
5.7 REGULATIONS IN EUROPE:
5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:
5.9 DATA PRIVACY PROTECTION IN EUROPE:
5.1 REGULATIONS IN INDIA:
5.11 RELEVANT ACTS FOR THIS FRAMEWORK:
5.12 DATA PRIVACY PROTECTION IN INDIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 GROWING GERIATRIC POPULATION
6.1.3 RISING PER CAPITA INCOME
6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION
6.2 RESTRAINTS
6.2.1 HIGH COST OF SERVICES
6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS
6.3 OPPORTUNITIES
6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 INCREASED REIMBURSEMENT POLICIES
6.3.4 RISING DISEASE MANAGEMENT PROGRAMS
6.4 CHALLENGE
6.4.1 LACK OF ACCESSIBILITY
7 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.4 CONCLUSION
8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 SOLUTION
8.3 SERVICES
9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE
9.1 OVERVIEW
9.2 ON PREMISE SOLUTION
9.3 WEB BASED SOLUTION
9.4 CLOUD BASED SOLUTION
10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE
10.1 OVERVIEW
10.2 IMPLEMENTATION SERVICES
10.3 CONSULTING SERVICES
10.4 EDUCATION SERVICES
10.5 OTHERS
11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION
11.1 OVERVIEW
11.2 CARDIOVASCULAR DISEASES (CVD)
11.3 DIABETES
11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)
11.5 ASTHMA
11.6 ARTHRITIS
11.7 CANCER
11.8 OTHERS
12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER
12.1 OVERVIEW
12.2 HEALTHCARE PROVIDERS
12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY
12.2.2 DIAGNOSTIC & IMAGING CENTERS
12.2.3 AMBULATORY CARE CENTERS
12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES
12.2.5 OTHERS
12.3 HEALTHCARE PAYERS
12.3.1 PUBLIC PAYERS
12.3.2 PRIVATE PAYERS
12.4 OTHERS
13 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 ISRAEL
13.1.5 EGYPT
13.1.6 REST OF MIDDLE EAST & AFRICA
14 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 IBM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 KONINKLIJKE PHILIPS N.V.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 COGNIZANT
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 ALLSCRIPTS HEALTHCARE, LLC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SOLUTION PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 ALTRUISTA HEALTH
16.5.1 COMPANY SNAPSHOT
16.5.2 SOLUTION PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 CASENET, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT & SERVICE PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 CEDAR GATE TECHNOLOGIES
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CLIEXA, INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 SOLUTION PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 EPIC SYSTEMS CORPORATION
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EXLSERVICE HOLDINGS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 HEALTH CATALYST
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 HINDUJA MIDDLE EAST AND AFRICA SOLUTIONS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 INFOSYS LIMITED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SOLUTION PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 MEDECISION
16.14.1 COMPANY SNAPSHOT
16.14.2 SOLUTION PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MINES & ASSOCIATES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 NXGN MANAGEMENT, LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 PEGASYSTEMS INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SCIENCESOFT USA CORPORATION
16.18.1 COMPANY SNAPSHOT
16.18.2 INDUSTRY PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 TCS HEALTHCARE TECHNOLOGIES
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 VIVIFY HEALTH, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 SOLUTION PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 WELLSKY
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 ZEOMEGA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.
TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS
TABLE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 40 SOUTH AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 41 SOUTH AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 46 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 SAUDI ARABIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 48 SAUDI ARABIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 49 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 50 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 U.A.E. SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 55 U.A.E. SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 56 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 57 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 U.A.E. HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 U.A.E. HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 ISRAEL SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 62 ISRAEL SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 64 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 ISRAEL HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 ISRAEL HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 EGYPT SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 69 EGYPT SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 70 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 71 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 72 EGYPT HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 EGYPT HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 74 REST OF MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)
FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)
FIGURE 20 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020
FIGURE 21 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020
FIGURE 29 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020
FIGURE 33 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020
FIGURE 37 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)
FIGURE 41 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)
FIGURE 42 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)
FIGURE 45 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
